RBC Life Sciences Inc. announced unaudited consolidated earnings results for the third quarter ended September 30, 2012. For the quarter, the company reported net sales of $6,713,000 compared to $7,061,000 a year ago. Operating loss was $525,000 compared to $486,000 a year ago.

Loss before income taxes was $556,000 compared to $521,000 a year ago. Net loss was $323,000 or $0.01 per basic and diluted share compared to $290,000 or $0.01 per basic and diluted share a year ago.